Next Article in Journal
Diversity Analysis of Intestinal Bifidobacteria in the Hohhot Population
Next Article in Special Issue
Evidence for Immunity against Tetanus, Diphtheria, and Pertussis through Natural Infection or Vaccination in Adult Solid Organ Transplant Recipients: A Systematic Review
Previous Article in Journal
Goethite Enhances Cr(VI) Reduction by S. oneidensis MR-1 under Different Conditions: Mechanistic Insights
Previous Article in Special Issue
BKPyV DNAemia in Kidney Transplant Recipients Undergoing Regular Screening: A Single-Centre Cohort Study
 
 
Article
Peer-Review Record

Monocentric, Retrospective Study on Infectious Complications within One Year after Solid-Organ Transplantation at a Belgian University Hospital

Microorganisms 2024, 12(4), 755; https://doi.org/10.3390/microorganisms12040755
by Céline Van Den Daele 1, Delphine Martiny 2, Isabelle Etienne 3, Delphine Kemlin 4, Ana Roussoulières 5, Youri Sokolow 6, Desislava Germanova 7, Thierry Gustot 8, Leda Nobile 9 and Maya Hites 1,*
Reviewer 2:
Microorganisms 2024, 12(4), 755; https://doi.org/10.3390/microorganisms12040755
Submission received: 9 March 2024 / Revised: 29 March 2024 / Accepted: 1 April 2024 / Published: 9 April 2024
(This article belongs to the Special Issue Infections in Solid Organ Transplant Recipients)

Round 1

Reviewer 1 Report

Comments and Suggestions for Authors

Authors present an interseting analysis of post-transplant infectious complications. Generally, article is well prepared and worth publishing. I would suggest some changes:

1. A low vaccination rate for S. pneumoniae and influenza. How frequent were S. pneumoniae and influenza infections in the cohort? Could you prepare an analysis of vaccinated vs unvaccinated patients, at least in regard to S. pneumoniae?

2. Lines 86-87: is that the period of transplantation or the period of observation? Please clearly indicate.

There are several typos in the text, please double-check and correct.

Author Response

Review 1 :

1. A low vaccination rate for S. pneumoniae and influenza. How frequent were S. pneumoniae and influenza infections in the cohort? Could you prepare an analysis of vaccinated vs unvaccinated patients, at least in regard to S. pneumonia?

Thank you for your comment.
We had 3 patients who developed a pneumonia due to Streptococcus pneumoniae  (without associated bacteremia), 2 of whom were vaccinated against S. pneumoniae.
Concerning influenza infections, there were 7 identified individuals with Influenza infections.  This information has been added into the manuscript. 

2. Lines 86-87: is that the period of transplantation or the period of observation? Please clearly indicate

Thank you for your comment.  I apologize for the lack of clarity. We collected transplant data during 2018 and 2019 and each patient was followed for 1 year. We have modified our text to try to add clarity.

3. There are several typos in the text, please double-check and correct

Thank you once again for your comment. We have verified the text and made adaptations.

Reviewer 2 Report

Comments and Suggestions for Authors

- In European countries, chronic infection of hepatitis E virus in SOT patients under immunosuppressive treatment has been a concern. Therefore, mentioning or inclusion of such cases in this study would be necessary.

- In view of this data (Table 3), chronic Viral hepatitis caused by HBV, HCV and HEV need to be mentioned in Introduction as well as Methodology sections.

- the English language should be reviewed.

For detailed comments (highlighted), please see the attached manuscript file (.pdf).

 

Comments for author File: Comments.pdf

Comments on the Quality of English Language

Needs to be improved.

Author Response

Review 2 :

  1.  In European countries, chronic infection of hepatitis E virus in SOT patients under immunosuppressive treatment has been a concern. Therefore, mentioning or inclusion of such cases in this study would be necessary.
  2. In view of this data (Table 3), chronic Viral hepatitis caused by HBV, HCV and HEV need to be mentioned in Introduction as well as Methodology sections.

Thank you for your important comment. I have added the data regarding previous hepatitis B and C infections in the methodology section as well as in table 3.

Unfortunately, we did not collect data on hepatitis E serology during the pre-transplant period.  We therefore cannot provide this information, unless re-submitting our research project to the ethics committee.

 

 

Round 2

Reviewer 2 Report

Comments and Suggestions for Authors

The revised version looks good and satisfactory.

Back to TopTop